ARKUDA THERAPEUTICS
Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. Arkuda’s lead compounds aim to correct progranulin deficiency and lysosomal dysfunction in GRN-related frontotemporal dementia (FTD-GRN), a genetically-defined subtype of frontotemporal dementia caused by an autosomal dominant mutation in the GRN gene.
ARKUDA THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.arkudatx.com
Total Employee:
11+
Status:
Active
Contact:
857-201-2789
Email Addresses:
[email protected]
Total Funding:
108 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Biocytogen
Biopharmaceutical company.
Circadian Therapeutics
Circadian Therapeutics is a Pharmaceutical company.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Arkuda Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series B - Arkuda Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Arkuda Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Arkuda Therapeutics
Eli Lilly
Eli Lilly investment in Series B - Arkuda Therapeutics
Mission BioCapital
Mission BioCapital investment in Series B - Arkuda Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series B - Arkuda Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Arkuda Therapeutics
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Arkuda Therapeutics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Arkuda Therapeutics
Official Site Inspections
http://www.arkudatx.com Semrush global rank: 4.36 M Semrush visits lastest month: 2.6 K
- Host name: 152.113.196.35.bc.googleusercontent.com
- IP address: 35.196.113.152
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
